Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

BACKGROUND: The association between early changes in albuminuria and kidney and cardiovascular events is primarily based on trials of renin-angiotensin system blockade. It is unclear whether this association occurs with sodium-glucose cotransporter 2 inhibition. METHODS: The Canagliflozin and Renal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Soc Nephrol
Autores principales: Oshima, Megumi, Neuen, Brendon L., Li, JingWei, Perkovic, Vlado, Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Mahaffey, Kenneth W., De Nicola, Luca, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Jardine, Meg J., Heerspink, Hiddo J.L.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2020
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7790219/
https://ncbi.nlm.nih.gov/pubmed/32998938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2020050723
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares